We have found that lovastatin, a natural compound first identified in the 1970s and one of the most widely used statins to lower cholesterol, upregulates the expression of miR-33b and reduces c-Myc expression and function in medulloblastoma cells (Daoy) with miR-33b alleles. Here, MYC is linked to medulloblastoma.